Alliance A022106: A phase II/III trial of NABPLAGEM vs nab-paclitaxel/gemcitabine as second-line treatment for BRCA1/2 or PALB2 mutant metastatic pancreatic ductal adenocarcinoma (PLATINUM)
- Citation:
- J Clin Oncol vol 24 (16_suppl) TPS4205
- Meeting Instance:
- ASCO 2024
- Year:
- 2024
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epreprint
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Erica S. Tsang Qian Shi Ken Olive Eric Collisson Jesse Dixon Mike Cusnir Ardaman Shergill Jeffrey Meyerhardt Eileen O'Reilly Andrew H. Ko
- Networks:
- CA136, COLUMBIA, LAPS-IL057, LAPS-MA036, LAPS-NY016
- Study
- Alliance-A022106
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2/3
- Keywords: